The impact of school disruptions: Lessons from the pandemic
New study led by CHÉOS Scientist Dr. Anne Gadermann will explore the impact COVID-related school disruptions have had on student and teacher wellbeing
Read MoreOctober 29, 2020
CHÉOS investigators are at the forefront of health outcomes research, including health economics, pharmacoeconomics and patient-reported outcomes. Their work evaluates the effectiveness of health interventions in populations to inform policies, transforming health systems at the local, national and international levels in the future.
New study led by CHÉOS Scientist Dr. Anne Gadermann will explore the impact COVID-related school disruptions have had on student and teacher wellbeing
Read More
CHÉOS Scientist Dr. Christopher Fordyce chaired the writing of a new American Heart Association Scientific Statement, “Prevention of Complications in the Cardiac Intensive Care Unit”
Read More
The WHO-funded study shows that dolutegravir is the optimal choice for first-line treatment of HIV
Read More
New research from the CHÉOS Health Economics Program finds market factors and pricing policies may be to blame
Read More
CHÉOS Scientists are testing the cost-effectiveness of a new blood test that aims to avoid the unnecessary health complications and costs of current methods
Read More
In recognition of World Hepatitis Day on July 28, CHÉOS Scientist Dr. Naveed Janjua discusses the BC Hepatitis Testers Cohort
Read More